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In the first step of flavivirus replication, the 5′-end of viral genomic RNA is thought to interact with the 3′-end of the genomic RNA at the
complimentary sequences (CSs) located at both ends of the genomic RNA. However, there is little evidence of direct interaction between the two
ends of the viral genomic RNA in virus-replicating cells. Herein, we show that viral small negative-strand RNA species, composed of two ends
corresponding to the upstream of the 5′-end CS and the downstream of the 3′-end CS of viral genomic RNA, were synthesized during viral
replication. We hypothesized that the viral small negative-sense RNAs were synthesized during viral negative-sense RNA synthesis through the
template-jumping of viral RNA-dependent RNA polymerase from the 3′-end to the 5′-end of viral genomic RNA used as a template. Our present
results strongly indicate that the two ends of viral genomic RNA associate with each other during viral replication.
© 2007 Elsevier Inc. All rights reserved.Keywords: WNV; Replication; Complimentary octa-nucleotide sequence; small RNAsIntroduction
West Nile virus (WNV) causes the mosquito-borne diseases,
West Nile (WN) fever and WN encephalitis, in a variety of
animals including humans and horses. WNV belongs to the
family Flaviviridae and has a positive-sense, single-strand
RNA genome. Most members of the virus family Flaviviridae,
including WNV, yellow fever virus, Japanese encephalitis virus
(JEV), and tick-borne encephalitis virus, cause arthropod-borne
encephalitis (van Regenmortel et al., 2000). After flavivirus
attachment to the cell surface receptors, the virus internalizes
and penetrates into cells using a low pH-dependent endocytic
pathway (Chu and Ng, 2004; Heinz and Allison, 2003;
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and/or viral proteases, and then viral proteins are maturated.
Subsequently, the viral replication complex (RC) is formed and
is associated with the endoplasmic reticular (ER) or Golgi
membranes (Grun and Brinton, 1988). The molecular architec-
ture of the initial RC is thought to consist of a number of viral
nonstructural (NS) proteins, NS1, NS2A, NS2B, NS3, NS4A,
NS4B, and NS5; cellular proteins, p108, p105, p84, p60, p50,
and p42; elongation factor 1α, Mov34, TIA-1, and TIAR
(Blackwell and Brinton, 1995, 1997; Li et al., 2002; Shi et al.,
1996b; Ta and Vrati, 2000; Westaway et al., 1997); and also
viral RNA. The viral negative-sense, genome-sized RNA is
transcribed from the viral positive-sense genomic RNA, of
approximately ∼11 kilo bases (kb) in size in the RC. Then,
positive-sense viral genomic RNA is transcribed using the
negative-sense, genome-sized RNA as its template.
The complimentary sequences (CSs) of WNVare positioned
at both ends of the viral genomic RNA; the 3′-CS cor-
responding to positions 10,925 to 10,932 and the 5′-CS whose
sequence is complementary to the 3′-CS, corresponding to
Fig. 1. Detection and characterization of the WNV small RNAs. Total RNAs
were extracted from mock-infected Vero E6 cells (lanes 1 and 4), from Vero E6
cells infected with WNV at 48 hours post infection (h.p.i.) (lanes 2 and 5), and
from the culture medium of Vero E6 cells infected with WNV (lanes 3 and 6).
Two micrograms of each RNA sample was run on 1% formaldehyde-denatured
agarose gel and blotted onto nylon membranes. Viral specific RNAs on the
membrane were hybridized with the 5′-end (lanes 1 to 3) or the 3′-end probes
labeled with DIG (lanes 4 to 6). DIG on the membrane was then detected with a
DIG-specific antibody as described in Materials and methods. The arrowhead
and the arrow indicate the genomic RNA and the small RNA of WNV,
respectively.
131A. Maeda et al. / Virology 371 (2008) 130–138positions 137 to 144 (Hahn et al., 1987; Khromykh et al., 2001;
Westaway et al., 2003). This, therefore, implies that the
genomic RNA of WNV forms a cyclized-panhandle structure.
Furthermore, putative pseudoknot (PK) structures have been
predicted at the 5′- and the 3′-end regions of the genomic
positive- as well as the negative-sense RNAs. Ultraviolet cross-
linking and site-directed mutagenetic studies of the CSs have
suggested the importance of cyclization of the genomic RNA
for negative-sense RNA synthesis in cells infected with
flaviviruses, Dengue virus (DENV)-2 (You et al., 2001), and
Kunjin virus (KUNV) (Khromykh et al., 2001; Westaway et al.,
2003). Lo et al. precisely characterized the interaction between
the 5′- and the 3′-CS during viral RNA replication using WNV
replicons (Lo et al., 2003). Recently, an electromicroscopic
study by Filomatori et al. showed that DENV RNA cyclizes
during the replication cycle (Filomatori et al., 2006) and more
recently, the viral NS5, which is thought to be a viral RNA-
dependent RNA polymerase (RdRp), was found to bind to the
5′-terminal 3–4 nucleotides (nt) of the WNV genomic RNA
(Dong et al., 2007). These reports have provided strong
evidence for the interaction between the 5′- and the 3′-ends of
viral genomic RNA.
In addition to viral genomic RNA, other species of viral
subgenomic-sized RNAs have also been identified (Naeve and
Trent, 1978; Takeda et al., 1978; Wengler et al., 1978). How-
ever, the structures of these RNAs have not yet been clarified.
Recently, Lin et al. showed that small viral RNAs are produced
during the replication of JEV and characterized the structure of
the small viral RNAs of JEV in detail (Lin et al., 2004).
Surprisingly, the viral small RNAs are comprised of only the
positive-sense, 3′-end sequence of viral genomic RNA and are
approximately ∼600 nt in size. Although Lin et al. suggested
that the small viral RNAs regulated viral replication and
persistency in the flavivirus-infected cells (Lin et al., 2004),
further evidence is required to prove this hypothesis. Such viral
small RNAs are also produced in the Eg101 strain of WNV
(WNV-Eg101)-infected cells (Scherbik et al., 2006).
Herein, we show that viral small RNAs with sizes between
300 to 600 nt were also produced in WNV-infected cells. We
also characterize the small RNA species of WNV and discuss
how and why they were synthesized in viral replicating cells.
Results
Synthesis of WNV small RNA in viral infected cells
To examine the replication of WNV RNA in virus-infected
cells, we extracted total cellular RNAs from Vero E6 cells
infected with the WNV-Eg101 (Smithburn et al., 1940), FCG
(WNV-FCG, Castle et al., 1985), or g2266 strains of WNV
(WNV-g2266, Lanciotti et al., 1999) and performed Northern
blot analysis using viral 3′-end specific probes labeled with
digoxigenin (DIG). As shown by other researchers (Lin et al.,
2004; Naeve and Trent, 1978; Scherbik et al., 2006), we detected
not only viral genome-sized RNA, but also∼500-nt-sized RNA
species in the WNV-Eg101 (Fig. 1, lane 5), WNV-FCG, and
WNV-g2266-infected cells (data not shown). Additionally, ourresults showed that the viral small RNAs, which were detected in
WNV-infected cells, were not packaged into virus particles
(Fig. 1, lane 6 and Fig. 2B, lane 2). In this study, we choseWNV-
Eg101 as a model virus to characterize the viral small RNAs.
Structural characterization of the WNV small RNAs
To characterize the viral small RNAs, we performed
Northern blot analysis using the 5′- and the 3′-end probes for
the detection of the 5′ and the 3′ regions of the viral RNA,
respectively. Our results showed that the majority of the WNV
small RNAs had the 3′-end sequence (Fig. 1 lane 5) but not the
5′-end sequence of WNV genome-sized RNA (Fig. 1, lanes 2).
We hypothesized that WNV small RNAs were composed of at
least two types of RNA species; one containing only the 3′-end
sequence of viral positive-sense RNA and the other a viral
defective interfering (DI) RNA, which contained the sequences
of both ends of viral genomic RNA. The majority of viral small
RNAs were thought to be the former, which could be de-
tected by Northern blot analysis using the 3′-end probe, but not
the 5′-end probe (Fig. 1).
In this paper, we examined the possibility that a minor
population ofWNV small RNAswere viral replicating DI RNAs.
If this were the case, we could amplify the viral small RNAs by
using the 5′- and the 3′-end primers forWNVas both ends of viral
genomic RNA should be responsible for viral RNA replication.
The reverse transcription (RT) reaction was carried out using the
total RNA extracted from Vero E6 cells infected with WNVas a
template and a random hexamer as a primer. Then, the cDNA
containing the 5′- and the 3′-end sequences of WNV genomic
RNA was amplified by polymerase chain reaction (PCR) using
oligos #1 and #2 corresponding to the 5′-end and the 3′-end
sequences, respectively (Table 1). As a result, ∼500-nt RNA
sequences containing the 5′- and the 3′-end regions ofWNVwere
Fig. 2. WNV small RNAs containing the 5′- and the 3′-end sequences of the viral genomic RNA. (A) The viral small RNAs containing the 5′- and the 3′-end sequences
of viral genomic RNA were amplified using cDNAs synthesized from the total RNAs of the cells infected with WNV. The cDNA was reverse-transcribed using a
random hexamer as a primer, and amplified using oligos #1 and #2 as primers (lane 2). No amplified products were observed using the mock-infected cells (lane 1).
The vertical black bar indicates the amplified products. M: 100-bp ladder size marker. (B) No viral small RNAs were present in virus particles. Virion RNAs were
extracted from the virus particles (lane 2) or mock-infected culture medium (lane 1). RT-PCRwas performed under the same conditions as in Fig. 2A. M: 100-bp ladder
size marker. (C) The amplified products were ligated into the pCRBlunt-II plasmid and the insertions in the cloned plasmids were amplified by PCRs using oligos #1
and #2 as primers. We show here the nine independent plasmid clones (pCRB-II sRNAs, clone numbers #1 to #12). M: 100-bp ladder size marker. The 500-bp DNA
marker is shown as a horizontal line, C; PCR using an empty pCRB-II plasmid as a template for a negative control. (D) The sequences of the inserts of pCRB-II sRNA
clones were determined and schematically drawn. The full-length genomic RNA of WNV is shown at the top of the figure. The closed arrowheads indicate the CSs
located at nucleotides 137 to 144 (5′-CS) and 10,925 to 10,932 of the genomic RNA (3′-CS). The sequences of the CSs are shown at the bottom of the scheme. Total
nucleotide (nt) lengths of the small RNAs are shown on the right. The numbers shown within each clone indicate the corresponding sites of the genomic RNA
sequences of the Eg101 strain of WNV. The dotted lines shown in each clone indicate the missing sequences of viral genomic RNA within the viral small RNA.
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viral genomic RNA or the viral small RNAs using purified virion
RNA as a template and the same primer set for RT-PCR (Fig. 2B,
lane 2). This result eliminates the possibility that the viral small
RNAs are synthesized during their cDNA synthesis. The PCR
products of∼500 base pair (bp) in size were then ligated into the
pCRBlunt-II plasmid. We obtained nine independent clones
(pCRB-II sRNAs clones #1 to #12) from a single PCR product.
The inserted PCR products of the pCRBlunt-II plasmids
were confirmed by PCR using oligos #1 and #2 (Fig. 2C). The
sequences of the inserted cDNAs were determined by cycle
sequencing and are schematically shown in Fig. 2D. These
cDNAs contained both end sequences of the viral genomicRNAs,
including the viral CSs located at each end, except for clone #9,
which had a truncated 6-nt sequence, UCAAUA, in place of the 8-
nt sequence, UCAAUAUG, of the 5′-end CS.
To examine the polarity of the viral small RNAs containing the
5′- and the 3′-end regions of viral genomic RNA, we performed
strand-specific RT-PCRs. First, we evaluated the ability of our RT-
PCR protocol to specifically amplify the positive- or the negative-
sense RNA. Positive- (+RNA) and negative-sense (−RNA)
artificial RNAs containing the Aequorea coerulescens greenfluorescent protein (AcGFP) gene sequence flanked by the 5′- and
the 3′-end sequences ofWNVwere synthesized in vitro (Fig. 3A).
These RNAs were mixed with Vero E6 cell lysate and extracted
from the mixture as described in Materials and methods.
Subsequently, the strand-specific RT-PCR was carried out using
these RNAs as templates. Firstly, we attempted the amplification
of the +RNA using oligo #2 as the RT primer, and then the
synthesized cDNAwas amplified using oligos #1 and #2 as PCR
primers (Fig. 3B and 3C). We could specifically amplify the
+RNA (Fig. 3C, lane 1), but not the −RNA (Fig. 3C, lane 3).
Next, we performed a similar experiment to amplify the −RNA
using oligo #1 as the RT primer and oligos #1 and #2 as PCR
primers (Fig. 3B and C). Similarly, we could amplify the −RNA
(Fig. 3C, lane 4), but not the +RNA (Fig. 3C, lane 2). On the basis
of these results, we concluded that our strand-specific RT-PCR
worked sufficiently well for our research. Next, we tried to
amplify the sequence of the viral small RNAs encoding both
sequences of the 5′- and the 3′-end by our strand-specific RT-PCR
using the RNA extracted from virus-infected cells (Fig. 3D).
Surprisingly, we could amplify only the negative-sense RNAs
(Fig. 3D, lane 1), but not the positive-sense RNAs (Fig. 3D, lane
3). We then confirmed this result by nested RT-PCR using oligos
Table 1
Oligonucleotides (Oligos) used in this experiment
Oligo # Sequence a Position b Polarity c Restriction enzymes
1 AGTAGTTCGCCTGTGTGAGCTG 1–22 F
2 AGATCCTGTGTTCTCGCA 11,012–11,029 R
3 CGAGATCTATGTCTAAGAAACCAGGAG 97–115 F
4 ACCAGCCACCATTGTCGGCG 10,990–11,009 R
5 GAGAGGATCC ATTTAGGTGACACTATAGAGTAGTTCGCCTGTGTGAGCTGA 1–23 F BamHI
6 TCGGTA CCTGCTCCCACGCTGGCGATCAAGCC 442–465 R KpnI
7 AGAAGTTTATCTGTGTGAACTT JEVd, 1–22 F
8 AGATCCTGTGTTCTTACTC JEVd, 10,959–10,977 R
9 CAGT ACGCGT GCGGCCGC CTTCAGTCCAATCAAGGAC 171–189 R MluI, NotI
10 TAAATACTTTATTAATTG 10,396–10,413 F
11 CAA TCTAGA GATCCTGTGTTCTCGCACCAC 11,008–11,02 R XbaI
12 A GCGGCCGC AGTCGCCACCATGGTGAGCA AcGFP e F NotI
13 C GCGGCCGC CTTGTACAGCTCATCCATGC AcGFP e R NotI
14 GG ATTTAGGTGACACTATAG AGATCCTGTGTTCTCGCACCAC 11,007–11,029 R
15 TAGAGGAGACCCCGCGGTTTAAAG 10,811–10,835 F
a Oligonucleotide sequences are shown from the 5′ terminal to the 3′ terminal. Underlined sequences are the recognition sites of the restriction endonucleases. The
SP6 RNA polymerase promoter sequences are shown in italics.
b The binding site of the oligonucleotide within the WNV-Eg101 sequence.
c Oligonucleotide orientation. F: sense, R: reverse orientation.
d This sequence is derived from the full-length sequence of JEV-JaGAr 01 (AF069076).
e This sequence is encoding the pAcGFP1 plasmid (CLONTECH).
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amplify the negative- (Fig. 3D, lane 2), but not the positive-sense
RNAs (Fig. 3D, lane 4).
The synthetic ratio of viral negative-sense small RNAs during
viral negative-sense RNA synthesis
To estimate the ratio of the viral negative-sense small RNA
synthesis during viral negative-sense RNA synthesis, we per-
formed highly sensitive Northern blot analysis using a DIG-
labeled, sense-directed RNA (sense-Ribo)-probe. To prepare the
sense-Ribo-probe, we amplified the sequence of sRNA#7 using
pCRB-II sRNA#7 as a template and oligo #9 and #5 containing an
SP6 RNA polymerase promoter sequence as PCR primers. In
vitro transcription was performed using SP6 polymerase, and the
RNAswere labeled with DIG during in vitro transcription. Firstly,
we confirmed the specificity of the polarity of the synthesized
Ribo-probe. The negative-sense sRNA#7 RNA and positive-
sense WNV RNA were run on a denatured gel, blotted onto a
nylon membrane, and probed with the sense-Ribo-probe. Results
showed that our sense-Ribo-probe specifically recognized the
negative-sense sRNA#7 RNA (Fig. 4A, lane 1), but not the
positive-sense WNV-RNA (Fig. 4A, lane 2), confirming the
effectiveness of the strand-specific Northern blot analysis. We
then tried to detect the viral negative-sense, genome-sized RNA
and the viral negative-sense small RNAs in virus-replicating cells.
We successfully detected the RNAs using the sense-Ribo-probe
and estimated the ratio of viral negative-sense small RNAs to viral
negative-sense, genome-sized RNAs to be 0.53, as shown in
Fig. 4A, lane 3. Additionally, we prepared an antisense-directed
RNA-probe (antisense-Ribo-probe) to detect viral positive-sense
RNAs. The membrane, which was used in the previous
experiment, was de-probed and then re-probed with the
antisense-Ribo-probe. We successfully detected viral positive-sense RNAs (Fig. 4B, lane 2), but not the in vitro transcribed viral
negative-sense RNA (Fig. 4B, lane1), again confirming the
effectiveness of our strand-specific Northern blot analysis in
detecting viral positive-sense RNAs in this experiment. Re-
probing of the membranewas performedwith the antisense-Ribo-
probe. We detected the positive-sense genome-sized and small
RNAs in the WNV-infected cells (Fig. 4B, lane 3) and the ratio of
these RNAs was 0.85, as shown in Fig. 4B.
Viral negative-sense small RNAs in WNV-NY and JEV-JaGAr
01 replicating cells
We also examined the presence of viral negative-sense small
RNAs in WNV strain NY (WNV-NY)-, and other flavivirus,
JEV strain JaGAr 01 (JEV-JaGAr 01)-replicating cells. Fig. 5
clearly shows that viral small RNA species of this kind were
synthesized in the WNV-NY- and JEV-JaGAr 01-infected cells
(Fig. 5, lanes 2 and 4, respectively).
Discussion
In this paper, we have shown that there were at least two viral
small RNA species in the WNV-replicating cells. Although
structural characterization of the viral small RNAs has not yet
been performed precisely, Takegami et al. have reported that
viral small RNAs are produced in flavivirus-infected cells
(Takegami and Hotta, 1990). Recently, Lin et al. reported that
the viral small RNAs are composed from just the 3′-end
sequence of the genomic RNA of JEV with a size of 521 to 523
nt (Lin et al., 2004). One of the viral small RNA species of
WNV, which was identified by Scherbik et al. (2006), has a
similar RNA structure to that reported previously for JEV small
RNA (Lin et al., 2004). This type of viral small RNA contained
just the 3′-end sequence of the viral positive-sense genomic
Fig. 3. Polarity of the viral small RNAs containing the 5′- and the 3′-end
sequences of the viral genome-sized RNA. To examine the effectiveness of our
strand-specific RT-PCR in this experiment, positive- (+RNA) and negative-
strand (-RNA) RNAs were synthesized by SP6 RNA polymerase using pCRB-5′
WNV/AcGFP/3′WNV (A-A) or pCRB-3′WNV/AcGFP/5′WNV (A-B) as
templates for in vitro transcription, respectively. The SP6 RNA polymerase
promoter sequence is shown as open triangles. The 5′-, the 3′-ends of the WNV
genome sequence, and the sequence of AcGFP gene are also shown
schematically. (B) Oligos used in this experiment are shown schematically.
Their directions are indicated as arrows and their binding sites are plotted on the
baseline of WNV genome. (C) In vitro-transcribed +RNA and −RNA were
mixed with Vero E6 cell lysate, and again extracted. We were able to amplify the
positive-sense RNAs using oligo #2 as the RT primer (lane 1), but not using #1
(lane 2). In contrast, the negative-sense RNAs were amplified using oligo #1 as
the RT primer (lane 4), but not #2 (lane 3). The arrow and the arrowhead indicate
the amplified full-length cDNA of 5′WNV/AcGFP/3′WNVor 3′WNV/AcGFP/
5′WNV RNA, and the location of ∼500 bp-sized DNA, respectively. (D) To
confirm the polarity of the viral small RNAs, we performed strand-specific RT-
PCR (lanes 1 and 3) and strand-specific nested RT-PCR (lanes 2 and 4) using the
primers shown in panel B.
Fig. 4. Detection of WNV negative- and positive-sense RNAs by using strand-
specific RNA (Ribo)-probes. (A) In vitro-transcribed, negative-sense sRNA#7
(lane 1), positive-sense WNV RNA (lane 2), and total cellular RNA extracted
from the Vero E6 cells infected with WNV-Eg101 (lane 3) were blotted onto
nylon membranes and probed using the sense-Ribo-probe. WNV negative-
sense, genome-sized RNA and negative-sense, small RNAs are indicated by the
arrowhead and the arrow, respectively. The asterisk indicates an unknown
reacted RNA species with the sense-Ribo-probe. The ratio of the amount of the
negative-sense small RNAs to that of the viral negative-sense, genome-sized
RNA ([Small RNAs] / [Genome-sized RNA]) was 0.53, as shown at the bottom
of panel A. (B) The membrane, which was used in the experiment in panel A,
was re-probed with the antisense Ribo-probe to detect viral positive-sense
RNAs. The antisense Ribo-probe reacted with only the positive-sense WNV
RNA (lane 2), but not with the negative-sense RNA (lane 1). We detected the
positive-sense genome-sized (open triangle) and also small-sized (open arrow)
RNA in the WNV-infected cells (lane 3). The ratio of the amounts of these
RNAs was 0.85, as show at the bottom of panel B.
Fig. 5. Viral negative-sense, small RNAs in WNV-NY- and JEV-JaGAr 01-
replicating cells. Vero E6 cells were infected with WNV-NY (lanes 1 and 2) or
JEV-JaGAr 01 (lanes 3 and 4) at a multiplicity of infection (m.o.i.) of 10 and the
cellular RNAwas extracted at 48 h.p.i. Using these RNA samples, viral positive-
(as shown by +, lanes 1 and 3) and negative-sense, small RNAs (as shown by −,
lanes 2 and 4) were amplified by strand-specific RT-PCRs as described in the
text. M: 100-bp DNA ladder marker.
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species were of this kind, they could be detected in the WNV-
replicating cells by standard Northern blot analysis using a
double-stranded cDNA probe labeled with DIG (Fig. 1). The
other species of viral small RNA identified in the WNV-infected
cells by RT-PCR was composed of negative-sense RNAs
including both the 5′- and the 3′-end sequences of negative-
sense, genome-sized RNA. Although it may be argued that
these small RNAs are artificial products produced during the
detection steps, especially during the cDNA synthesis step,
using WNV genomic RNA as a template, it should be noted that
we were unable to amplify the small-sized viral RNA species
using purified virion RNAs (Fig. 2B, lane 2). Furthermore, wealso detected the viral negative-sense small RNAs in WNV-NY-
and JEV-JaGAr 01-replicating cells (Fig. 5). These results
provide convincing evidence for the presence of the viral
negative-sense small RNAs in flavivirus-replicating cells
generally. Additionally, we were unable to detect positive-
sense small RNAs containing the complimentary sequences of
the negative-sense small RNA (Fig. 3D, lanes 3 and 4).
Therefore, as these RNAs do not act as templates for replication,
this type of small RNAs is thought not to be a viral DI RNA.
Fig. 6A shows the predicted interaction sequences (boxed
sequences) of the 5′- and the 3′-end regions of WNV genomic
RNA and the predicted tertiary interactions at each sequence of
both ends of the genomic RNA (Khromykh et al., 2001; Shi
et al., 1996a,b). The CSs at each end of WNV RNA (the 5′-CS
Fig. 6. Predicted RNA structures of the 5′- and the 3′-ends regions of the
positive-sense, genomic RNA and the fusion sites between the 5′- and the 3′-end
sequences within the viral small RNAs. (A) We predicted the formation of one
conserved pseudoknot (PK) structure at the 5′-end and three PKs (PK1, PK2 and
PK3) at 3′-end region. The predicted tertiary interaction sites are shown as PK1',
PK2' and PK3', respectively. The predicted tertiary interactions between PK1
and PK1', PK2 and PK2′, and PK3 and PK3′ are shown by dotted lines. The
conserved 5′- and the 3′-CSs are shown as solid boxes on a modification of
Brinton's figure (Brinton, 2002). (B) The fusion sites between the 5′- and the 3′-
end sequences on the sequence of WNV genomic RNA corresponding to the
negative-sense viral small RNAs are plotted by their cloned numbers.
Fig. 7. Proposed schematic model of the synthesis of viral negative-sense small
RNAs in the WNV replication cycle. After viral penetration into the cells, viral
RC could be formed by RdRp, other viral replicating proteins, some cellular
proteins responsible for viral replication, and viral positive-sense genomic RNA
associated with the replication site between the ER and the Golgi complex (A).
Subsequently, the negative-sense genome-sized RNAwas synthesized from the
positive-sense genomic RNA as a template (B). It is possible that, viral RdRp
accidentally jumps from a site very close to the 3′-CS of viral genomic RNA to
the 5′-CS during viral negative-sense RNA synthesis. As a result, viral negative-
strand small RNAs are synthesized during viral replication (C). CSs are shown
as crossed-boxes. Positive- and negative-sense RNAs are marked as (+) and (−),
respectively. The synthetic direction of negative-sense RNA is indicated by the
arrows.
135A. Maeda et al. / Virology 371 (2008) 130–138and the 3′-CS), the sequences of which are complementary, are
thought to interact with each other for cyclization of viral
genomic RNA during the viral replication cycle (Hahn et al.,
1987; Khromykh et al., 2001; Westaway et al., 2003). PK
structures at the 3′-end region, PK1, PK2, and PK3, are thought
to undergo tertiary interactions with PK1′, PK2′, and PK3′,
respectively (Brinton, 2002). We plotted the sequence positions
at which the 5′-end sequence fused with the 3′-end sequence of
the genomic RNA within the viral negative-sense small RNAs
as shown in Fig. 6B. All of the negative-sense viral small RNAs
contained the complementary sequence of the 5′-end sequence
upstream of the 5′-CS of viral genomic RNA and the
complementary sequence of the 3′-end sequence downstream
of the 3′-CS of viral genomic RNA. It is worthy of note that the
fusion sites of the 5′-end regions of all negative-sense small
RNAs were located at sites between PK3 and PK2′ (Fig. 6B).
These results suggest that the cis- or trans-template-jumping of
viral RdRp from the 3′- to the 5′-end of viral genomic RNA
occurred at a site very close to the CSs during viral negative-
sense RNA synthesis. Our proposed model of the viral RdRp
template-jumping during viral negative-sense RNA synthesis is
shown schematically in Fig. 7. According to our model, viral
RdRp generally synthesizes a viral negative-sense, genome-
sized RNA using viral positive-sense, genome-sized RNA as a
template (Fig. 7B). However, the viral RdRp might produce the
negative-sense small RNA accidentally through the template-
jumping mechanism of viral RdRp (Fig. 7C). Our present
results suggest that the 5′-end of viral genomic RNA associates
with the 3′-end of viral genomic RNA during the viral
replication cycle in vivo. Thus, our results support the
hypothesized of viral genome cyclization mechanism during
viral replication reported by other researches (Filomatori et al.,
2006; Hahn et al., 1987; Khromykh et al., 2001; Westaway et
al., 2003; Lo et al., 2003; Dong et al., 2007). The ratio of the
amount of the negative-sense small RNAs to that of thenegative-sense genome-sized RNAs, which might correspond
to the incidence of template-jumping mutations of WNV RdRp,
was surprisingly high at 0.53 (Fig. 4B). It might be possible that
viral negative-sense RNAs acts an important role for viral
replication. However, we are unable to clarify the mechanism
underlying this phenomenon in this time.
A possible mechanism for the generation of the positive-
sense viral small RNAs reported by Lin et al. in JEV (Lin et al.,
2004) and Scherbic et al. in WNV (Scherbik et al., 2006) is that
the positive-sense viral small RNAs are transcribed from
degraded genomes or from the negative-sense small RNAs as
templates during viral replication. Alternatively, the positive-
sense small RNAs might be degraded RNAs of viral genomic
RNAs. As the sequence of the viral positive-sense small RNAs
was predicted to form secondary or tertiary structures, this
highly structured region might be stabilized by viral or host-
derived proteins against digestion by RNases, except RNaseL
(Scherbik et al., 2006).
Unfortunately, the biological significance of the role of
positive- and negative-sense viral small RNAs in the flavivirus
replicating cycle remains unclear. However, recently, many non-
cording small RNAs, such as micro RNAs, have been shown to
modulate cellular functions, cell proliferation and cell death
(Brennecke et al., 2003), cell differentiation (Chen, 2004), brain
development (Krichevsky et al., 2003), and viral infection
(Lecellier et al., 2005; Pfeffer et al., 2004). Lin et al. suggested
that the viral small RNAs regulate viral replication and
persistence in the host cells (Lin et al., 2004) like the DI RNA
of many viruses. The DI RNA of flaviviruses is thought to
regulate viral replication and their persistence in the cells
infected with flaviviruses (Brinton, 1981; Brinton and Fernan-
dez, 1983; Debnath et al., 1991; Schmaljohn and Blair, 1977;
136 A. Maeda et al. / Virology 371 (2008) 130–138Urosevic et al., 1997). We are also interested in the possibility
that the role of the small RNA species of WNV is to regulate not
only cellular functions but also viral replication. We are now
preparing an experiment to clarify the biological roles of such
viral small RNA species in flavivirus-replicating cells.
Materials and methods
Viruses and cells
The Eg101 strain of WNV (GenBank accession no.
AF260968) was used throughout in this study. The FCG
(M12294), G2266 (AF196525), and NY strains of WNV
(AF260967) and the JaGAr 01 strain of JEV (AF069076) were
also used in some of our experiments. The viruses were
propagated in Vero E6 cells and titrated by plaque assay. Vero
E6 cells were grown in Dulbecco's modified Eagle′s medium
supplemented with 10% fetal calf serum.
RNA extraction and Northern blot analysis
Vero E6 cells were infected with WNV at a multiplicity of
infection (m.o.i.) of 10. Forty-eight hours post infection (h.p.i.),
total cellular RNAs were extracted from the cells infected with
WNV using TRIZOL reagent (Invitrogen), and the virion RNA
was extracted from the culture supernatant of the virus-infected
cells at 48 h.p.i. using TRIZOLLS reagent (Invitrogen). Northern
blot analysis was performed as described previously (Narayanan
et al., 2000). To synthesize a WNV 5′-end probe, a 465-nt
fragment corresponding to nucleotides 1 to 465 of WNV was
reverse transcribed using a random hexamer as a primer at 42 °C
for 30 min using AMV-RT. The sequence of the indicated region
was amplified by PCR using oligos #1 and #6 as primers
(Table 1). The reaction was carried out for 30 cycles of 94 °C for
30 s for denaturation, 55 °C for 30 s for annealing, and 72 °C for
1 min for extension. To construct a 3′-end probe for the detection
of the viral 3′-end RNA sequence, a 624-nt fragment of the
terminal 3′-end sequence of WNV, corresponding to nucleotides
10,198 to 10,882, was prepared by digestion of the plasmid
pCRBlunt-II WNV3′NCR, which contained the NS5 and 3′-non-
coding region (NCR) of WNV, with restriction enzymes AatII
and SacII. The DNA fragment for the 3′-end probe was separated
on 1% TBE agarose gel and purified from the gel. The 5′- and the
3′-end fragments were labeled with DIG using a DIG-High Prime
labeling Kit (Roche) according to the manufacturer's protocol.
Viral RNAs were run on a formaldehyde-denatured 1% agarose
gel, blotted onto nylon membranes, and hybridized with the DIG-
labeled probes at 50 °C overnight. DIG-labeled probes hybridized
with viral RNAon themembranewere detected by aDIG-specific
antibody according to the manufacturer's protocol.
RT-PCR for detection of viral RNAs
The WNV cDNAs were reverse-transcribed at 42 °C for
30 min using AMV-RT from the viral specific RNAs, extracted
from Vero E6 cells infected withWNVusing TRIZOL reagent, as
a template. We used 2 μg of total cellular RNA or 1 μg of virion-extracted RNA as templates for the RT reaction, and oligo #1 as
the RT primer for viral negative-sense RNA, and oligo #2 as the
primer for viral positive-sense RNA (Table 1). To amplify the viral
small RNAs containing the 5′- and the 3′-end sequences of viral
genomic RNAs, we used oligos #1 and #2 as PCR primers and
oligos #3 and #4 as nested PCR primers for the viral small RNAs
(Table 1). The reactions were performed for 30 cycles of 94 °C for
30 s for denaturation, 55 °C for 30 s for annealing, and 72 °C for
1 min for extension. We examined the presence of viral negative-
sense small RNAs in WNV-NY- or JEV-JaGAr 01-infected cells.
To detect the positive- or negative-sense small RNAs of WNV-
NY, we used oligo #1 or #2, respectively, as the RT primer. For the
detection of positive- or negative-sense small RNAs of JEV-
JaGAr 01, we used oligo #7 or #8, respectively. Then, PCRs were
performed using oligos #1 and #2 for WNV-NYor oligos #7 and
#8 for JEV-JaGAr 01, respectively.
Construction of plasmids
To construct plasmids expressing an Aequorea coerulescens
green fluorescent protein (AcGFP) flanked by the 5′- and the
3′-end sequences of WNV, corresponding to nucleotides 1 to 189
and 10,369 to 11,029, respectively (Fig. 3A), we first amplified
the 5′- and the 3′-end sequences of WNVusing oligos #5 and #9,
#10 and #11, respectively, as primer sets (Table 1). Oligo #5
contained a SP6 RNA polymerase promoter sequence to drive in
vitro RNA transcription by SP6 RNA polymerase. Each PCR
product was inserted into the pCRBlunt-II vector (Invitrogen),
and the sequences and direction in the plasmid were confirmed.
We selected plasmids pCRB-5′WNV and pCRB-3′WNV, in
which the 5′WNV and 3′WNV sequences were inserted in the
sense and reverse direction, respectively, for further plasmid
construction. pCRB-3′WNV was digested with restriction
enzymes NotI and XbaI, and the fragment containing the 3′-end
sequence of WNV was purified by column and inserted into the
NotI/XbaI site of pCRB-5′WNV, referred to as pCRB-5′/3′WNV.
The AcGFP sequence was amplified using pAcGFP1 (CLON-
TECH) as a template, and oligos #12 and #13 as PCR primers
(Table 1). The PCR fragment was digested withNotI and inserted
into theNotI site of pCRB-5′/3′WNV.We then selected one clone
in which the AcGFP sequence was inserted in the sense direction
(referred to as pCRB-5′WNV/AcGFP/3′WNV). Using this
plasmid, we synthesized a positive-sense RNA, composed of
5′-5′WNV/AcGFP/3′WNV-3′, by in vitro transcription. To con-
struct a plasmid expressing a reverse-directed RNA of 5′WNV/
AcGFP/3′WNV, we amplified the entire sequence of 5′WNV/
AcGFP/3′WNV using pCRB-5′WNV/AcGFP/3′WNV as tem-
plate and oligos #1 and #2 as primers. The PCR fragment was
inserted into the pCRBlunt-II plasmid in the reverse direction and
was referred to as pCRB-3′WNV/AcGFP/5′WNV.
In vitro transcription
Positive- and negative-sense RNAs, 5′-5′WNV/AcGFP/3′
WNV-3′ (+RNA) and 5′-3′WNV/AcGFP/5′WNV-3′ (−RNA),
were in vitro-transcribed using a mMESSAGEmMACHINE kit
(Ambion). Briefly, pCRB-5′WNV/AcGFP/3′WNV and pCRB-
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1 unit of Mung bean nuclease (Promega) to produce blunt-end
in the digested sites, and then supplied to in vitro transcription
as templates. In vitro transcription was then performed ac-
cording to the manufacturer's protocol.
Strand-specific RT-PCR
To examine the strand specificity of our strand-specific RT-
PCR, 1 μg of in vitro-transcribed RNAs was mixed with Vero
E6 cell lysate extracted with a phosphate buffer (pH 7.4)
containing 1% Nonidet P-40 and 40 units of RNase inhibitor.
The mixture was incubated on ice for 10 min, and then RNA
was extracted from the mixture. cDNA was synthesized using
oligos #1 and #2 as the RT primers for negative- and positive-
strand RNAs, respectively (Table 1). The PCR was performed
as described above.
Preparation of RNA (Ribo-) probes
To make the sense- and antisense-Ribo-probes to detect viral
negative- and positive-sense RNAs, respectively, we amplified
the sequence of sRNA#7 cDNA using pCRB-II sRNA#7 as a
template, and oligos #5 and #9 as the PCR primer set for
constructing the sense-Ribo-probe, and oligos #14 and #15 for
constructing the antisense-Ribo-probe. As oligos #5 and #14
contain SP6 RNA polymerase promoter sequences, we can
drive the in vitro RNA synthesis using SP6 RNA polymerase.
We used a DIG RNA Labeling Kit (T7 and SP6) (Roche) for in
vitro transcription and labeling the RNAwith DIG. The amounts
of RNAs were estimated by measuring the band intensities on
the membrane using a MultiGauge-Ver3.0-software system
(FUJIFILM, Japan).
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